Clin2
NCT07591350Possibly a fitNot yet recruiting

MRI-guided ultrasound for drug-resistant focal epilepsy

Epilepsy

Part of Brain & nervous system clinical trials.

This trial tests a non-invasive treatment using MRI-guided focused ultrasound to treat focal epilepsy that hasn't improved with medication. If you are not a candidate for open brain surgery, this ultrasound approach might offer a new option.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
13 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • Your epilepsy has not improved with at least two different anti-seizure medicines.
  • An MRI scan shows a brain abnormality that is linked to your seizures.
  • Open surgery (craniotomy) is not a good option for you, for example because the lesion is deep, in a sensitive area, or you prefer not to have surgery.
  • You are able to have an MRI and do not have metal implants or other MRI-incompatible devices in your brain or skull.
  • You are not pregnant and, if you could become pregnant, you agree to use birth control during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07497178Not yet recruiting
Focused ultrasound for epilepsy in children

This trial tests a non-invasive procedure called magnetic resonance-guided focused ultrasound (MRgFUS) to treat epilepsy caused by brain lesions in children. This approach uses sound waves to target and destroy the lesion without surgery, which may reduce seizures.

NCT07680842Recruiting
Non-invasive ultrasound for drug-resistant epilepsy

This study tests a non-invasive focused ultrasound treatment for people with epilepsy that doesn't respond to medications. The goal is to see if this gentle ultrasound can reduce seizures without surgery.

San Francisco, California
NCT06492720Recruiting
Testing focused ultrasound for drug-resistant epilepsy

This study tests a new device called NaviFUS that uses focused sound waves to gently stimulate a small area of the brain. It is for people whose seizures start in one part of the brain and are not fully controlled by seizure medicines.

Taipei
NCT06388707Recruiting· Phase 1/Phase 2
Ultrasound therapy for drug-resistant temporal lobe epilepsy

This study tests if a new, non-invasive ultrasound treatment can safely reduce seizures in people whose seizures start in the temporal lobe and have not been controlled by at least two anti-epileptic drugs. The ultrasound is delivered through the scalp to gently stimulate the brain area where the seizures begin.

Palo Alto, California
NCT06292494Recruiting
Focused ultrasound for drug-resistant epilepsy

This trial tests whether focused ultrasound can help people whose seizures are not controlled by two or more medications. You would have a noninvasive procedure while awake, pressing a stop button if needed, and your hair will be partially shaved.

Taipei
NCT07249190Not yet recruiting· Phase 1
Focused ultrasound for drug-resistant epilepsy

This trial tests a non-invasive treatment for hard-to-control epilepsy. Using MRI guidance, sound waves are focused on a small area in the brain to reduce seizures, offering a possible alternative to open surgery.

Hear when a new Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.